KARAKTERISTIK PASIEN DIABETES MELLITUS YANG MENGIKUTI PROGRAM SKRINING RETINOPATI DIABETIK BERBASIS KOMUNITAS DI KOTA BANDUNG OLEH RUMAH SAKIT MATA CICENDO PADA TAHUN 2022
DOI:
https://doi.org/10.11594/ojkmi.v5i3.59Keywords:
karakteristik, retinopati diabetik, skrining komunitasAbstract
Pendahuluan: Retinopati diabetik merupakan komplikasi mikrovaskular yang diakibatkan oleh penyakit diabetes mellitus kronis. Retinopati diabetik memerlukan skrining sebagai deteksi dini untuk mengontrol keparahannya.
Metode: Penelitian ini bertujuan untuk mengetahui karakteristik pasien retinopati diabetik yang terjaring skrining oleh Rumah Sakit Mata Cicendo pada tahun 2022 serta kelompok yang rentan yang mengalami retinopati diabetik. Karakteristik pasien dikategorikan menjadi karakteristik demografi, klinis, dan status oftalmologis. Desain penelitian ini berupa studi deskriptif potong lintang menggunakan data kuesioner skrinining pasien yang dilakukan pada tahun 2022.
Hasil: Rumah sakit mata cicendo berhasil melakukan skrining terhadap 435 pasien. Data yang terkumpul menunjukkan pasien yang mengikuti skrining mayoritas perempuan (71,49%), berusia 60-79 tahun (64,6%), memiliki riwayat hipertensi (66,44%), dan memiliki durasi diabetes 5-10 tahun (42,99%). Prevalensi DR dan VTDR dari pasien diabetes mellitus yang mengikuti skrining adalah 20,23% dan 3,68%. Mayoritas pasien berjenis kelamin perempuan (21,54%), kelompok umur 40-59 tahun (23,36%), memiliki riwayat hipertensi (20,76%), memiliki riwayat dislipidemia (22,22%) dan durasi diabetes 5-10 tahun (25,13%) mengalami retinopati diabetik.
Kesimpulan: Retinopati diabetik rentan terjadi pada orang dengan jenis kelamin perempuan, umur 40-59 tahun, riwayat hipertensi, riwayat dislipidemia, dan durasi diabetes 5-10 tahun.
Downloads
References
Shukla U V, Tripathy K. Diabetic Retinopathy [Internet]. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560805/#:~:text=Diabeti
World report on vision. Geneva; 2019.
Soewondo P, Soegondo S, Suastika K, Pranoto A, Soeatmadji DW, Tjokroprawiro A. The DiabCare Asia 2008 study – Outcomes on control and complications of type 2 diabetic patients in Indonesia. 2010 Oct;19:235–44.
Indonesia diabetes report 2000 — 2045 [Internet]. 2021 [cited 2023 Feb 1]. Available from: https://www.diabetesatlas.org/data/en/country/94/id.html
Halim A, Rini M, Ratnaningsih N, Iskandar E, Sovani I, Virgana R, et al. Prevalence and Associated Factors of Diabetic Retinopathy in People with Type 2 Diabetes Attending Community Based Diabetic Retinopathy Screening in Greater Bandung. International Journal of Retina (IJRETINA) 2022. 5(1).
Wang W, Lo ACY. Diabetic retinopathy: Pathophysiology and treatments. Vol. 19, International Journal of Molecular Sciences. MDPI AG; 2018.
Riordan-Eva P, Augburger JJ. Vaughan & Asbury’s General Opthalmology. 19th ed. 2018.
Toh H, Smolentsev A, Bozadjian R V., Keeley PW, Lockwood MD, Sadjadi R, et al. Vascular changes in diabetic retinopathy—a longitudinal study in the Nile rat. 2019 May 17 [cited 2023 Feb 1]; Available from: https://www.nature.com/articles/s41374-019-0264-3
Burton MJ, Ramke J, Marques AP, Bourne RRA, Congdon N, Jones I, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Vol. 9, The Lancet Global Health. Elsevier Ltd; 2021. p. e489–551.
Sasongko MB, Widyaputri F, Agni AN, Wardhana FS, Kotha S, Gupta P, et al. Prevalence of Diabetic Retinopathy and Blindness in Indonesian Adults With Type 2 Diabetes. Am J Ophthalmol. 2017 Sep 1;181:79–87.
Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012 Mar;35(3):556–64.
Tabel Batas Ambang indeks Massa tubuh (IMT) [Internet]. 2019. Available from: https://p2ptm.kemkes.go.id/infographicp2ptm/obesitas/
Pangribowo S. Infodatin Diabetes Mellitus. Pusat Data dan Informasi Kementerian Kesehatan RI. 2020;
Kementerian Kesehatan RI. Klasifikasi Hipertensi - Direktorat P2PTM. 2018 May 12 [cited 2023 Feb 1]; Available from: https://p2ptm.kemkes.go.id/infographic/klasifikasi-hipertensi
Awa WL, Fach E, Krakow D, Welp R, Kunder J, Voll A, et al. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120 183 patients from the German/Austrian DPV database. Eur J Endocrinol. 2012 Aug;167(2):245–54.
Li M, Wang Y, Liu Z, Tang X, Mu P, Tan Y, et al. Females with Type 2 Diabetes Mellitus Are Prone to Diabetic Retinopathy: A Twelve-Province Cross-Sectional Study in China. J Diabetes Res. 2020 Apr 21;2020:1–9.
Cherchi S, Gigante A, Spanu M, Contini P, Meloni G, Fois M, et al. Sex-Gender Differences in Diabetic Retinopathy. Diabetology. 2020 Apr 20;1(1):1–10.
Magliah S, Bardisi W, Al Attah M, Khorsheed M. The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals. J Family Med Prim Care. 2018;7(5):975.
Leley SP, Ciulla TA, Bhatwadekar A. Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment. Clin Interv Aging. 2021 Jul;Volume 16:1367–78.
Raja SA, Chong VH, Rahman NA, Shakir LMP, Knights J. Prevalence and Associated Factors of Diabetic Retinopathy among Type 2 Diabetes Mellitus Patients in Brunei Darussalam: A Cross-sectional Study. Korean Journal of Ophthalmology. 2022 Feb 1;36(1):26–35.
Zegeye AF, Temachu YZ, Mekonnen CK. Prevalence and factors associated with Diabetes retinopathy among type 2 diabetic patients at Northwest Amhara Comprehensive Specialized Hospitals, Northwest Ethiopia 2021. BMC Ophthalmol. 2023 Jan 5;23(1):9.
Alemu Mersha G, Alimaw YA, Woredekal AT. Prevalence of diabetic retinopathy among diabetic patients in Northwest Ethiopia—A cross sectional hospital based study. PLoS One. 2022 Jan 21;17(1):e0262664.
Hao Z, Huang X, Qin Y, Li H, Tian F, Xu R, et al. Analysis of factors related to diabetic retinopathy in patients with newly diagnosed type 2 diabetes: a cross-sectional study. BMJ Open. 2020 Feb 10;10(2):e032095.
Wahiduzzaman M, Islam MS, Hossain S, Hussain QMI, Banning F, Lechner A. Prevalence and factors associated with diabetic retinopathy among type 2 diabetic patients in Bangladesh: a hospital based cross-sectional study. Int J Community Med Public Health. 2023;
Liu Y, Yang J, Tao L, Lv H, Jiang X, Zhang M, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ Open. 2017 Sep 1;7(9):e016280.
Yao X, Pei X, Yang Y, Zhang H, Xia M, Huang R, et al. Distribution of diabetic retinopathy in diabetes mellitus patients and its association rules with other eye diseases. Sci Rep. 2021 Aug 20;11(1):16993.
John F. Salmon. KANSKI Clinical Ophthalmology. 9th ed. Elsevier; 2020.
Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Vol. 44, Clinical and Experimental Ophthalmology. Blackwell Publishing; 2016. p. 260–77
Liu L, Quang ND, Banu R, Kumar H, Tham YC, Cheng CY, et al. Hypertension, blood pressure control and diabetic retinopathy in a large population-based study. PLoS One. 2020 Mar 5;15(3):e0229665.
Hao Z, Huang X, Qin Y, Li H, Tian F, Xu R, et al. Analysis of factors related to diabetic retinopathy in patients with newly diagnosed type 2 diabetes: a cross-sectional study. BMJ Open. 2020 Feb 10;10(2):e032095.
Ezhilvendhan K, Sathiyamoorthy A, Prakash Bj, Bhava Bs, Shenoy A. Association of dyslipidemia with diabetic retinopathy in type 2 diabetes mellitus patients: A hospital-based study. J Pharm Bioallied Sci. 2021;13(6):1062.
Chang YC, Wu WC. Dyslipidemia and Diabetic Retinopathy. The Review of Diabetic Studies. 2013;10(2–3):121–32.
Raman R, Vasconcelos JC, Rajalakshmi R, Prevost AT, Ramasamy K, Mohan V, et al. Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban–rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectional screening study. Lancet Glob Health. 2022 Dec;10(12):e1764–73.
Eyth E, Roopa, Authors N, Affiliations N. Hemoglobin A1C [Internet]. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549816/
Almutairi NM, Alahmadi S, Alharbi M, Gotah S, Alharbi M. The Association Between HbA1c and Other Biomarkers With the Prevalence and Severity of Diabetic Retinopathy. Cureus. 2021 Jan 6;
Lind M, Pivodic A, Svensson AM, Ólafsdóttir AF, Wedel H, Ludvigsson J. HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. BMJ. 2019 Aug 28;l4894.
Wen L, Wang Y, Lin Z, Wang FH, Ding XX, Li D, et al. The Prevalence and Causes of Visual Impairment in Type 2 Diabetes Mellitus in Northeast China. J Ophthalmol. 2020 Nov 29;2020:1–7.
Purola PKM, Ojamo MUI, Gissler M, Uusitalo HMT. Changes in Visual Impairment due to Diabetic Retinopathy During 1980–2019 Based on Nationwide Register Data. Diabetes Care. 2022 Sep 1;45(9):2020–7.
Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045. Ophthalmology. 2021 Nov;128(11):1580–91.
Mersha GA, Woredekal AT, Tesfaw MT. Sight-threatening diabetic retinopathy and associated risk factors among adult diabetes patients at debre tabor general hospital, Northwest Ethiopia. Clinical Ophthalmology. 2020;14:4561–9.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Oftalmologi: Jurnal Kesehatan Mata Indonesia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a 